BNP Paribas Financial Markets’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$465K Buy
39,916
+31,255
+361% +$364K ﹤0.01% 2600
2025
Q1
$64.4K Sell
8,661
-22,051
-72% -$164K ﹤0.01% 3373
2024
Q4
$184K Sell
30,712
-25,108
-45% -$151K ﹤0.01% 3075
2024
Q3
$286K Buy
55,820
+45,521
+442% +$233K ﹤0.01% 2392
2024
Q2
$37.3K Sell
10,299
-52,842
-84% -$191K ﹤0.01% 2840
2024
Q1
$203K Buy
63,141
+20,710
+49% +$66.5K ﹤0.01% 2583
2023
Q4
$208K Sell
42,431
-35,332
-45% -$173K ﹤0.01% 2494
2023
Q3
$424K Buy
77,763
+47,956
+161% +$261K ﹤0.01% 2162
2023
Q2
$200K Sell
29,807
-35,695
-54% -$240K ﹤0.01% 2403
2023
Q1
$578K Buy
65,502
+25,953
+66% +$229K ﹤0.01% 2060
2022
Q4
$302K Sell
39,549
-44,514
-53% -$340K ﹤0.01% 2199
2022
Q3
$599K Buy
84,063
+46,095
+121% +$328K ﹤0.01% 2206
2022
Q2
$307K Buy
37,968
+29,483
+347% +$239K ﹤0.01% 2289
2022
Q1
$118K Buy
8,485
+5,359
+171% +$74.4K ﹤0.01% 2756
2021
Q4
$87.7K Buy
3,126
+3
+0.1% +$84 ﹤0.01% 2993
2021
Q3
$106K Buy
3,123
+1,447
+86% +$49.2K ﹤0.01% 2658
2021
Q2
$68.5K Sell
1,676
-1,655
-50% -$67.6K ﹤0.01% 2561
2021
Q1
$134K Buy
3,331
+594
+22% +$23.9K ﹤0.01% 2665
2020
Q4
$162K Buy
2,737
+1,557
+132% +$92.1K ﹤0.01% 2338
2020
Q3
$57.4K Sell
1,180
-1,774
-60% -$86.3K ﹤0.01% 2784
2020
Q2
$143K Buy
2,954
+1,340
+83% +$64.8K ﹤0.01% 2023
2020
Q1
$44.8K Buy
1,614
+825
+105% +$22.9K ﹤0.01% 2984
2019
Q4
$23.6K Buy
789
+119
+18% +$3.56K ﹤0.01% 3280
2019
Q3
$20.7K Buy
+670
New +$20.7K ﹤0.01% 3293